196597-26-9/Ramelteon

Quick Details
Molecular Formula:C16H21NO2
Molecular Weight:259.348
Appearance:crystalline solid
CasNo:196597-26-9

  • Product Details

    Ramelteon Good Manufacturer supply High Quality 196597-26-9

    • Molecular Formula:C16H21NO2
    • Molecular Weight:259.348
    • Appearance/Colour:crystalline solid 
    • Vapor Pressure:1.77E-08mmHg at 25°C 
    • Melting Point:113-115 °C 
    • Refractive Index:1.555 
    • Boiling Point:455.3 °C at 760 mmHg 
    • PKA:16.37±0.46(Predicted) 
    • Flash Point:229.2 °C 
    • PSA:38.33000 
    • Density:1.119 g/cm3 
    • LogP:2.95850 

    Ramelteon (196597-26-9) Usage

    Unlike most treatments of insomnia that target the GABA (g-aminobutyric acid) receptor complex, ramelteon is an agonist of the melatonin receptor. In particular, it has high selectivity for the MT1 and MT2 subtypes, which have been implicated in the maintenance of circadian rhythms, over the MT3 receptor responsible for other melatonin functions. Its lack of affinity for not only the GABA receptor complex but also neurotransmitter, dopaminerigic, opiate, and benzodiazepine receptors suggests an improved safety profile devoid of the abuse potential of the hypnotic drugs that target these receptors. As such, ramelteon is not a scheduled drug. Primary metabolites include hydroxylation and oxidation to carbonyl species with secondary metabolites resulting from glucuronidation. Since CYP1A2 is the major isozyme involved in the hepatic metabolism of ramelteon, it should not be taken in combination with strong CYP1A2 inhibitors, such as fluvoxamine. Co-administration with either ketoconazole (a CYP3A4 inhibitor) or fluconazole (a potent CYP2C9 inhibitor) resulted in significant increases in AUC and Cmax, but the extensive metabolism and highly variable plasma concentrations of ramelteon precluded the need for dose modification. The package insert, however, cautions patients about co-administration with potent CYP3A4 and CYP2C9 inhibitors. Based on the result of the clinical trials, the recommended dose of ramelteon is 8mg taken within 30 min of going to bed. In addition to the precaution of co-administration with CYP inhibitors, it should not be used in patients with severe hepatic impairment. The adverse events, observed in 5% of patients in clinical studies, were somnolence, dizziness, nausea, fatigue, headache, and insomnia.

    How to get the best price on Ramelteon?

    Zibo Hangyu Biotechnology Development Co., Ltd is a quality supplier and manufacturer of Ramelteon . You can buy high quality, low price Ramelteon 196597-26-9 here.

    Zibo Hangyu Biotechnology Development Co., Ltd. is a comprehensive chemical enterprise focusing on fine chemical products and pharmaceutical intermediates, integrating research and development, production and sales. The company is equipped with advanced equipment quality inspection and research center. At the same time, the company has excellent talents with rich experience in process development and quality control. To provide customers with total solutions from raw material processing to chemical synthesis systems. The company has established a standardized and perfect quality standard system to provide stable and high quality production and service.

    Milestones

    • 2012yearThe company was founded, began to engage in the production and supply of chemical raw materials
    • 2014yearExpand the scale of production, pharmaceutical raw materials production workshop was established
    • 2016yearCooperated with domestic and foreign chemical platforms to promote self-produced and high-end pharmaceutical intermediates
    • 2019yearIn recent years to participate in the international pharmaceutical raw materials exhibitions
    • 2023yearBusiness continues to expand, Production and Sales teams continue to grow
    • 2026yearPlans to set up foreign branches


    Hot Tags: 196597-26-9/Ramelteon, Products, Others , 196597-26-9 Good Manufacturer,High Quality 196597-26-9,Good Manufacturer supply 196597-26-9
  • *Product Name
    CasNo
    Quantity
    Company Name
    *Email
    *Description
    *Code
    Items marked with * are mandatory
    Submit